The response to antiangiogenic anticancer drugs that inhibit endothelial cell proliferation

DOI10.1016/J.AMC.2006.01.061MaRDI QIDQ856106zbMATH OpenOpenAlexFDO

Authors A. d'Onofrio, Alberto Gandolfi

Publication date 7 December 2006

Published in Applied Mathematics and Computation (Search for Journal in Brave)

Full work available at URL https://doi.org/10.1016/j.amc.2006.01.061

zbMATH Keywords

cancerangiogenesisFloquet's theory

Mathematics Subject Classification ID

Medical applications (general) (92C50) Qualitative investigation and simulation of ordinary differential equation models (34C60) Global stability of solutions to ordinary differential equations (34D23)

Recommendations

• Tumour eradication by antiangiogenic therapy: analysis and extensions of the model by Hahnfeldt et al. (1999)
• A family of models of angiogenesis and anti-angiogenesis anti-cancer therapy
• Periodic solutions for a model of tumor volume with anti-angiogenic periodic treatment
• A therapy inactivating the tumor angiogenic factors
• A mathematical model for the effect of anti-angiogenic therapy in the treatment of cancer tumours by chemotherapy

Cites work

• scientific article; zbMATH DE number 3134483 (Why is no real title available?)
• scientific article; zbMATH DE number 3247443 (Why is no real title available?)
• scientific article; zbMATH DE number 3254233 (Why is no real title available?)
• scientific article; zbMATH DE number 3297399 (Why is no real title available?)
• Globally stable vaccine-induced eradication of horizontally and vertically transmitted infectious diseases with periodic contact rates and disease-dependent demographic factors in the population
• Periodic motions
• Stability properties of pulse vaccination strategy in SEIR epidemic model
• Tumour eradication by antiangiogenic therapy: analysis and extensions of the model by Hahnfeldt et al. (1999)

Cited in

(11)

• Stability analysis of the family of tumour angiogenesis models with distributed time delays
• Effect of treatment on the global dynamics of delayed pathological angiogenesis models
• Multi-input optimal control problems for combined tumor anti-angiogenic and radiotherapy treatments
• On optimal delivery of combination therapy for tumors
• Optimal control for selected cancer chemotherapy ODE models: a view on the potential of optimal schedules and choice of objective function
• Resonance of the epidemic threshold in a periodic environment
• Anti-angiogenic therapy based on the binding to receptors
• On an extension of a mathematical model for tumor anti-angiogenesis
• A bi-parametric model for the tumour angiogenesis and antiangiogenesis therapy
• Analysis of the Hopf bifurcation for the family of angiogenesis models. II: The case of two nonzero unequal delays
• Tumor development under combination treatments with anti-angiogenic therapies

This page was built for publication: The response to antiangiogenic anticancer drugs that inhibit endothelial cell proliferation

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q856106)